ACM |
Alcoholic Cardiomyopathy |
ARVC |
Arrhythmigenic Right Ventricular Cardiomyopathy |
BRD4 |
Bromodomain-Containing Protein 4 |
CTRCD |
Cancer Therapy-Related Cardiac Dysfnction |
DCM |
Dilated Cardiomyopathy |
DNA |
Deoxyribonucleic Acid |
EZH2 |
Enhancer of Zeste Homolog 2 |
GWAS |
Genome-Wide Association Study |
HCM |
Hypertrophic Cardiomyopathy |
HCM-LVSD |
HCM with Left Ventricular Systolic Dysfunction |
iPS-CM |
Induced Pluripotent Stem Cell Derived Cardiomyocyte |
iPSC |
Induced Pluripotent Stem Cell |
KCCQ |
Kansas City Cardiomyopathy Questionnaire |
LD |
Linkage Disequilibrium |
LSD1 |
Lysine-Specific Histone Demethylase 1 |
LVEF |
Left Ventricular Ejection Fraction |
LVESVi |
Left Ventricular End-Systolic Volume Index |
LVRR |
Left Ventricular Reverse Remodeling |
MRI |
Magnetic Resonance Imaging |
NGS |
Next Generation Sequencer |
NT-proBNP |
N-Terminal Pro-Brain Natriuretic Peptide |
OM |
Omecamtiv Mecarbil |
PDGF |
Platelet-Derived Growth Factor |
PPCM |
Peripartum Cardiomyopathy |
RCM |
Restrictive Cardiomyopathy |
RNA-seq |
Ribonucleic Acid Sequencing |
SCD |
Sudden Cardiac Death |
SNP |
Single Nucleotide Polymorphism |